1)Unilateral breast cancer patients who fulfill either i) or ii) below i)Primary breast cancer of clinical stage 0 through III for which surgery and /or chemotherapy and / or radiotherapy has been completed as initial treatment and that is currently undergoing regular follow-up observations or postoperative endocrine therapy ii) Undergoing endocrine therapy or first-line through third-line chemotherapy for metastatic or recurrent cancer for at least 2 months
Conditions
Interventions
None listed
Sponsors
Japan Clinical Oncology Group (JCOG)
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1)Unilateral breast cancer patients who fulfill either i) or ii) below i)Primary breast cancer of clinical stage 0 through III for which surgery and/ or chemotherapy and / or radiotherapy has been completed as initial treatment and that is currently undergoing regular follow-up observations or postoperative endocrine therapy ii)Undergoing endocrine therapy or first-line through third-line chemotherapy for metastatic or recurrent cancer at least 2 months 2)Woman aged 20 - 79 years at the date of registration 3)No history of malignant tumor except forbreast cancer 4)No difficulty in reading and writing in Japanese 5)Have a copayment for medical fees (any copayment ratio allowed) 6)Not being administered a trial drug 7)Not a student 8)Written informed consent
Exclusion criteria
Exclusion criteria: Nothing
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| WTP for hypothetical scenarios | — |
Countries
Japan
Contacts
Public ContactTsuguo Iwatani
JCOG1709A Coordinating Office Department of Breast Surgery, National Cancer Center Hospital East
Outcome results
None listed